RA

Reyaz Ahmad Gojri

Active Director Designated Partner DIN 11262922
DIN 11262922 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Reyaz Ahmad Gojri

Data last updated:

Reyaz Ahmad Gojri is a Designated Partner at Meanwell Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11262922
Primary Designation Designated Partner
Industry Pharma
First Appointment 26 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Aug 20252025Active

Board colleagues of Reyaz Ahmad Gojri

NameDINCompanyDesignation
Muzamil Ali11262921Meanwell Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Meanwell Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Reyaz Ahmad Gojri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reyaz Ahmad Gojri

Reyaz Ahmad Gojri currently holds 1 directorship: Meanwell Pharmaceuticals Llp (Designated Partner, since 26 Aug 2025).

Reyaz Ahmad Gojri was first appointed on 26 Aug 2025 as Designated Partner at Meanwell Pharmaceuticals Llp.

The current boards of Reyaz Ahmad Gojri's companies include Muzamil Ali (Meanwell Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available